Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3525338018 | Pibrentasvir (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3525339014 | Pibrentasvir | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pibrentasvir | Is a | Pyrrolidine | true | Inferred relationship | Some | ||
| Pibrentasvir | Is a | Benzimidazole | true | Inferred relationship | Some | ||
| Pibrentasvir | Has disposition | Hepatitis C virus protein NS5A inhibitor | true | Inferred relationship | Some | ||
| Pibrentasvir | Is a | Hepatitis C virus protein NS5A inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Glecaprevir and pibrentasvir only product | Has active ingredient | True | Pibrentasvir | Inferred relationship | Some | 1 |
| Glecaprevir and pibrentasvir only product in oral dose form | Has active ingredient | True | Pibrentasvir | Inferred relationship | Some | 1 |
| Pibrentasvir-containing product | Has active ingredient | True | Pibrentasvir | Inferred relationship | Some | 1 |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has precise active ingredient | True | Pibrentasvir | Inferred relationship | Some | 1 |
| Glecaprevir 100 mg and pibrentasvir 40 mg oral tablet | Has BoSS | True | Pibrentasvir | Inferred relationship | Some | 1 |
| Glecaprevir- and pibrentasvir-containing product | Has active ingredient | True | Pibrentasvir | Inferred relationship | Some | 1 |
| Glecaprevir- and pibrentasvir-containing product in oral dose form | Has active ingredient | True | Pibrentasvir | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR